Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 30, 2026 · Filed Oct 1, 2026
On Sep 30, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 21,687 shares. Filed Oct 1, 2026 (Form 4).
- Awarded
- 168 shares
- Holding after
- 21,687 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Shares | Award | 168 | 21,687 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Evans Terry L
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Evans Terry L · Aug 31, 2026
- Form 4 · Evans Terry L · Aug 3, 2026
- Form 4 · Evans Terry L · Jul 1, 2026
- Form 4 · Evans Terry L · Jun 1, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026
- Form 4 · Hackman Jeffrey S. · Oct 13, 2026